Evolutionary Genomics

Evolutionary Genomics FCF per Share

The Free Cash Flow per Share of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is -0.10 USD. In the previous year, Free Cash Flow per Share was -0.27 USD — a change of -64.22% (higher).

FCF per Share

-0.10USD

YoY

-64.22%

Last updated:

Free Cash Flow per Share of Evolutionary Genomics is 2022 -0.10 USD. Free Cash Flow per Share of Evolutionary Genomics was 2021 -0.27 USD. It decreases by -64.22% higher compared to the previous year.

The Evolutionary Genomics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2015
-0.12 USD
Jan 1, 2016
-0.21 USD
Jan 1, 2017
-0.20 USD
Jan 1, 2018
-0.18 USD
Jan 1, 2019
-0.11 USD
Jan 1, 2020
-0.39 USD
Jan 1, 2021
-0.27 USD
Jan 1, 2022
-0.10 USD
The Evolutionary Genomics FCF per Share history
YEARFCF per ShareYoY
-0.10USD-64.22%
-0.27USD-31.09%
-0.39USD+267.00%
-0.11USD-40.72%
-0.18USD-10.34%
-0.20USD-2.67%
-0.21USD+67.37%
-0.12USD-38.61%
-0.20USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Free Cash Flow per Share of Evolutionary Genomics is -0.10 USD in 2022.

Free Cash Flow per Share of Evolutionary Genomics changed from -0.27 USD to -0.10 USD, representing a -64.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics